119 related articles for article (PubMed ID: 22713517)
1. Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier.
Yang F; Kamiya N; Goto M
Eur J Pharm Biopharm; 2012 Sep; 82(1):158-63. PubMed ID: 22713517
[TBL] [Abstract][Full Text] [Related]
2. A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium.
Piao H; Kamiya N; Hirata A; Fujii T; Goto M
Pharm Res; 2008 Apr; 25(4):896-901. PubMed ID: 17896098
[TBL] [Abstract][Full Text] [Related]
3. Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation.
Moniruzzaman M; Tamura M; Tahara Y; Kamiya N; Goto M
Int J Pharm; 2010 Nov; 400(1-2):243-50. PubMed ID: 20813174
[TBL] [Abstract][Full Text] [Related]
4. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
5. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
6. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
[TBL] [Abstract][Full Text] [Related]
7. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of topical delivery of methotrexate by electroporation.
Wong TW; Zhao YL; Sen A; Hui SW
Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
[TBL] [Abstract][Full Text] [Related]
9. [Water in oil microemulsions for transdermal delivery of fluorouracil].
Liu F; Xiao YY; Ping QN; Yang C
Yao Xue Xue Bao; 2009 May; 44(5):540-7. PubMed ID: 19618733
[TBL] [Abstract][Full Text] [Related]
10. Choline and amino acid based biocompatible ionic liquid mediated transdermal delivery of the sparingly soluble drug acyclovir.
Islam MR; Chowdhury MR; Wakabayashi R; Tahara Y; Kamiya N; Moniruzzaman M; Goto M
Int J Pharm; 2020 May; 582():119335. PubMed ID: 32311469
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
12. Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel.
Singka GS; Samah NA; Zulfakar MH; Yurdasiper A; Heard CM
Eur J Pharm Biopharm; 2010 Oct; 76(2):275-81. PubMed ID: 20600884
[TBL] [Abstract][Full Text] [Related]
13. [Microemulsion-based gel of fluorouracil for transdermal delivery].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
[TBL] [Abstract][Full Text] [Related]
14. A nano-sized gel-in-oil suspension for transcutaneous protein delivery.
Hardiningtyas SD; Nagao S; Yamamoto E; Shirakigawa N; Wakabayashi R; Goto M; Ijima H; Kamiya N
Int J Pharm; 2019 Aug; 567():118495. PubMed ID: 31276761
[TBL] [Abstract][Full Text] [Related]
15. Fractional laser-assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate.
Taudorf EH; Lerche CM; Erlendsson AM; Philipsen PA; Hansen SH; Janfelt C; Paasch U; Anderson RR; Haedersdal M
Lasers Surg Med; 2016 Jul; 48(5):519-29. PubMed ID: 26846733
[TBL] [Abstract][Full Text] [Related]
16. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes.
Zeb A; Qureshi OS; Kim HS; Cha JH; Kim HS; Kim JK
Int J Nanomedicine; 2016; 11():3813-24. PubMed ID: 27540293
[TBL] [Abstract][Full Text] [Related]
17. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine.
Zhang J; Michniak-Kohn B
Int J Pharm; 2011 Dec; 421(1):34-44. PubMed ID: 21959104
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions.
Shakeel F; Ramadan W
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):356-62. PubMed ID: 19783127
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of flurbiprofen from surfactant-based vesicles: particle characterization and the effect of water on in vitro transport.
Uchino T; Matsumoto Y; Murata A; Oka T; Miyazaki Y; Kagawa Y
Int J Pharm; 2014 Apr; 464(1-2):75-84. PubMed ID: 24445120
[TBL] [Abstract][Full Text] [Related]
20. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil.
Gupta RR; Jain SK; Varshney M
Colloids Surf B Biointerfaces; 2005 Mar; 41(1):25-32. PubMed ID: 15698753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
